Viewing StudyNCT00445588



Ignite Creation Date: 2024-05-05 @ 5:22 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00445588
Status: COMPLETED
Last Update Posted: 2016-04-27
First Post: 2007-03-07

Brief Title: Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Recurrent Adult Brain Tumor
Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Keywords: